NCT00910273View on ClinicalTrials.gov

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

PHASE4TerminatedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Ankylosing Spondylitis

Interventions

DRUG

etanercept

etanercept 50 mg/week

Trial Locations (4)

40138

Pfizer Investigational Site, Bologna

42100

Pfizer Investigational Site, Reggio Emilia

59100

Pfizer Investigational Site, Prato

00161

Pfizer Investigational Site, Roma

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Lincoln Medical and Mental Health Center

OTHER

lead

Pfizer

INDUSTRY